ASLAN Pharmaceuticals was founded in 2009. In 2016, the company obtained exclusive worldwide rights to develop and commercialize varlitinib from Bayer.
Peter Foley (Member of Scientific Advisory Board)
Mark Graham (Member of Scientific Advisory Board)
Jacob Thyssen (Member of Scientific Advisory Board)
Peter Sly (Member of Scientific Advisory Board)
Tim Hammond (Member of Scientific Advisory Board)
Lawrence F. Eichenfield (Chairman of Scientific Advisory Board)
Patrick G. Holt (Member of Scientific Advisory Board)
Carl Alan Jason Morton Firth (Founder, CEO & Executive Director)
Eric Simpson (Member of Scientific Advisory Board)
Melinda Jennifer Gooderham (Member of Scientific Advisory Board)
Neil Graham (Independent Director)
Kathleen M. Metters (Independent Director)
https://in.investing.com/equities/aslan-pharmaceuticals
https://www.crunchbase.com/organization/aslan-pharmaceuticals
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Andrew Howden (Independent Chairman)
Robert E. Hoffman (Independent Non-Executive Director)
John Dixon (Member of Scientific Advisory Board)